Led by Pfizer, co-led by Merck KGaA (Darmstadt, Germany) and coordinated by Universidad Politécnica de Madrid (UPM) the five-year project – “BEhavioral and Adherence Model for improving quality, health outcomes and cost-effectiveness of healthcaRe (BEAMER)” – brings together 27 European partners from academia, civil society and industry to jointly address adherence to treatment.
Discover the consortium driving change in health & care!
Universities/Research Organisations
Health & Care Providers/University Hospitals
Patient Organisations
Small and Medium-sized Enterprises (SMEs)
Non-profit Organisations
EFPIA and IMI2 Associated Partners
Supported by a grant from IMI, the project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101034369. This joint undertaking receives support from the European Union’s Horizon 2020 research and innovation programme, the European Federation of Pharmaceutical Industries and Associations [EFPIA] and Link2Trials. The total budget is 11.9 M€ for a project duration of 60 months.
Disclaimer:
Information on this website reflects project owner’s views and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained therein.
